CSI Market
Sign In | Register

Therapeutic Solutions International Inc (TSOI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TSOI Annual Cash Flow →
From Therapeutic Solutions International Inc through Sep 30 2023, changes in Sep 30 2024's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
9 Months 		(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Operating Activities
Income-3.26
Depreciation & amortization0.01
Amortization of Other Assets0.47
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Intangible Assets, Finite-lived0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.01
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation2.71
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Investment Income Net Amortization Of Discount And Premium-
Stock Granted During Period Value Sharebased Compensation-
Right To Use Asset-
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction0.06
Stock Based Compensation To Consultants-
Share Based Compensation To Related Parties0.06
Loss On Derivative Liabilities-
Gain Loss On Derivative Instruments Net Pretax-0.04
Amortization Of Prepaid Stock Based Compensation0.02
Increase Decrease In Right Of Use Asset0.02
Increase Decrease In Account Payable Related Parties-
Increase Decrease In Operating Lease Liability-0.02
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Accounts Payable0.01
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.16
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.44
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.03
Discontinued operations0.00
Net Cash flow from Operating Activities-0.28
Investing Activities
Capital Expenditures-0.15
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Acquisition Of Licensing Agreement-
Payments For Proceeds From Notes Receivable-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Proceeds from Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.05
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.10
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.17
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.18
Proceeds from Partnership Contribution0.00
Issuances / -repurchases of Pref. Stock0.01
Increase (Decrease) in Deposits0.00
Other financing activities net0.00
Other net0.00
Settlement Of Contractual Obligation-
Net Proceeds From Investments By Related Parties-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.36
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.42
Total Cash Flow-0.02
4 historic quarters locked

Sign in to unlock the full Therapeutic Solutions International Inc cash flow history.

Sign In Create Free Account

About Therapeutic Solutions International Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 20, 2024
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-24-046954

Figures are derived from filed reports and may be restated. Historical data is subject to revision.